Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.
about
Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group.French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesPhase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.Clofarabine in pediatric acute leukemia: current findings and issues.High-dose etoposide in allogeneic stem cell transplantation.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide.Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).Clofarabine experience in children with multi-relapsed acute leukemia.Use of clofarabine for acute childhood leukemia.Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial.A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children.Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancerPrognosis and outcome of relapsed acute lymphoblastic leukemia: A Hong Kong pediatric hematology and Oncology Study Group report
P2860
Q33711119-EE9AF601-F34C-4437-8D28-12A90026FF17Q35605949-5E6849F5-AACA-4E5D-9ED0-5E5EAD5BD55CQ36161733-08249C1B-DD38-499F-9C6C-49463EFC7F5BQ36689775-8DB9C959-B289-4EDD-B850-8BD0A1B60ABEQ36804215-3EBB1CC6-73D0-4BEA-B7B2-62F243754E92Q37064875-193A58EE-EFDD-49D6-81E0-00DEEE1B8F3FQ37987061-F09D678B-B07B-4837-9F89-926F1FE45D2AQ38051016-189C8096-9340-4885-847C-2187A7857FAAQ38097334-3CD1AD10-65E4-42AF-A45E-DEA728472D19Q38155455-3BCB58FA-419A-429D-997C-0F9267F87D34Q38226402-9C373722-D640-4CEA-85E9-AE6728155E32Q38669037-6500CB40-2C06-4E6A-BE54-129BD0F22E69Q38672607-CB73EC6E-8A2D-4681-A5B8-2C2B907E92BAQ40996804-15DA03D6-A903-4670-88F5-ABA578C8ABE3Q42127787-B557A8A4-187D-40BB-81BD-573CC8F3AC45Q42737704-9604C215-EBA4-4640-9806-9D26D116F52CQ44646134-D12BB4C2-0F6E-4573-A7BD-30A107EAAF91Q46971601-0EAA3096-AAA0-401C-A69D-F0E080AFF25DQ47614484-DD98B6E4-60F2-4C34-990B-18A0527BFD99Q48175362-01E8A96D-120B-486B-A87E-96D0633F9116Q48369402-DBE24AD3-36A8-4578-B04E-D2F347657A26Q52848310-C21AFC03-69C2-435F-88BB-9B2532B551A3Q53657116-DF081058-5A27-4912-92E8-507E17579B47Q57658700-12432980-9E53-44C4-8326-9E0E7C0DA445Q59103913-A314587B-EAF2-49D9-98C0-1A28808449AD
P2860
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@en
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@nl
type
label
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@en
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@nl
prefLabel
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@en
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@nl
P2093
P1476
Clofarabine, cyclophosphamide ...... acute lymphoblastic leukaemia.
@en
P2093
Alice Bertaina
Andrea Pession
Anna M Testi
Carmelo Rizzari
Eugenia Giraldi
Marco Zecca
Maria Ester Bernardo
Pietro Merli
Rosanna Parasole
Walter Barberi
P304
P356
10.1111/J.1365-2141.2009.07882.X
P407
P577
2009-08-29T00:00:00Z